Skye Bioscience hires the clinic – GuruFocus.com
San Diego, Calif., April 28, 2022 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (SKYE) (“Skye” or the “Company”), a pharmaceutical company developing proprietary synthetic cannabinoid derivatives to treat glaucoma and d ‘Other Diseases with Significant Unmet Need, has retained CMAX Clinical Research (“CMAX”) to facilitate the recruitment and administration of drugsRead More →